DB15806InvestigationalVaccines
CoronaVac, previously known as PiCoVacc, is a SARS-CoV-2 purified, inactivated, and adsorbed vaccine candidate developed by SinoVac Biotech Corporation . It was developed by propagating the SARS-CoV-2 CN2 strain inside... It was developed by propagating the SARS-CoV-2 CN2 strain inside Vero Cells and inactivating it with B-propiolactone[A219481;A219758].
- Also known as
- PiCoVacc
- Code names
- CoronaVac
Resolves to
Compound
What you can answer from here — as of September 05, 2026
Which companies are running trials of CoronaVac, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account